BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

American Journal of Human Genetics

Volumn 66, Issue 4, 2000, Pages 1259-1272

  Moslehi, Roxana ^a,d   Chu, William ^a   Karlan, Beth ^e   Fishman, David ^f   Risch, Harvey ^g   Fields, Abbie ^h   Smotkin, David ⁱ   Ben David, Yehuda ^j   Rosenblatt, Jacalyn ^k   Russo, Donna ^l   Schwartz, Peter ^g   Tung, Nadine ⁿ   Warner, Ellen ^b   Rosen, Barry ^c   Friedman, Jan ^d   Brunet, Jean Sébastien ^a   Narod, Steven A ^a,m  

^a UNIVERSITY OF TORONTO   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

^g YALE UNIVERSITY   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^j HAEMEK MEDICAL CENTER   (Israel)

^k MCGILL UNIVERSITY   (Canada)

^l New York State Psychiat Inst and New York Presbyterian Hospital Columbia University Medical Center   (United States)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; JEW; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

FALLOPIA;

EID: 0033927850     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302853     Document Type: Article

References (35)

1. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, et al (1997) The founder mutations 185deIAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505-514
2. Amos CI, Struewing JP (1993) Genetic epidemiology of epithelial ovarian cancer. Cancer 71:566-572
3. Beller U, Halle D, Catane R, Kaufman B, Hornereich G, Levy-Lahad E (1997) High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history. Gynecol Oncol 67: 123-126
4. Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Barakat RR, et al (1999) Clinical and pathologic features of hereditary ovarian cancers associated with germline mutations of BRCA1 or BRCA2. Gynecol Oncol 72: 444
5. Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310-1316
6. Brunet JS, Narod SA, Tonin P, Foulkes WD (1997) Survival rates in BRCA1 carriers with ovarian cancer. N Engl J Med 336:1256
7. Easton D, Ford D, Bishop D, Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 56:265-271
8. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695
9. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-689
10. Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BAJ, Stratton MR, et al (1997) Variation of risks of breast and ovarian associated with different germline mutations of the BRCA2 gene. Nat Genet 15:103-105
11. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiana M, Seal S, et al (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428-433
12. Janezic SA, Ziogas A, Krumroy LM, Krasner M, Plummer SJ, Cohen P, Gildea M, et al (1999) Germline BRCA1 alterations in a population-based series of ovarian cancer cases. Hum Mol Genet 8:889-898
13. Levy-Lehad E, Catane R, Eisenberg S, Kauffman B, Hornreich G, Lishinksy E, Shohat M, et al (1997) Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast cancer families. Am J Hum Genet 60:1059-1067
14. Modan B (1997) BRCA1 mutations and survival in women with ovarian cancer. N Engl J Med 336:1255
15. Modan B, Gak E, Sade-Baruchim R, Hirsch-Yechezkel G, Theodor L, Lubin F, Ben-Baruch G, et al (1996) High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. JAMA 276:1823-1825
16. Muto MG, Cramer DW, Tangir J, Berkowitz R, Mok S (1996) Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res 56:1250-1252
17. Narod SA, Ford D, Devilee P, Barkardottir RB, Eyfjord J, Lenoir GM, Serova O, et al (1995a) Genetic heterogeneity of breast-ovarian cancer revisited. Am J Hum Genet 57:957
18. Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BAJ, et al (1995b) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56:254-264
19. Narod SA, Lynch H, Conway T, Watson P, Fuenteun J, Lenoir GM (1993) Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet 341:1101
20. Narod SA, Madlensky L, Bradley L, Cole D, Tonin P, Rosen B, Risch HA (1994) Hereditary and familial ovarian cancer in Southern Ontario. Cancer 74:2341-2346
21. Oddoux C, Struewing JP, Clayton M, Neuhausen S, Brody LC, Kaback M, Haas B, et al (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188-190
22. Ozcelik HO, Schmocker B, Di Nicola N, Shi X-H, Langer B, Moore M, Taylor BR, et al (1997) Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 16:17-18
23. Parkin D, Muir C, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents, vol 7. IARC Scientific Publications, Lyon
24. Rebbeck TR, Levin AM, Eisen A, Snyder C, Lynch HT, Chittenden A, Garber JE, et al (1999) Reduction in breast cancer risk following bilateral prophylactic mastectomy in BRCA1 carriers. J Natl Cancer Inst 91:1475-1479
25. Risch HA (1998) Hormonal etiology of epithelial ovarian can-cer with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90:1774-1786
26. Roa B, Boyd A, Volcik K, Richards C (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187
27. Rubin SC, Benjamine I, Behbakht K, Takahashi H, Morgan MA, LiVolsi VA, Berchuk A, et al (1996) Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 335:1413-1416
28. Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J (1998) BRCA1, BRCA2 and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population. Relationship to family history and implications for genetic testing. Am J Obstet Gynecol 178:670-677
29. Stratton JF, Gayther SA, Russell PL, Dearden J, Gore M, Blake P, Easton D, et al (1997) Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336:1125-1130
30. Struewing J, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995a) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200
31. Struewing J, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
32. Struewing JP, Watson P, Easton DF, Ponder BA, Lynch HT, Tucker MA (1995b) Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst 17:33-35
33. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhasuen S, Godwin AK, et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179-1183
34. Wacholder S, Hartge P, Struewing JP, Pee D, McAdams M, Brody L, Tucker M (1998) The kin-cohort study for estimating penetrance. Am J Epidemiol 148:623-630
35. Warner E, Goodwin P, Foulkes W, Meschino W, Goss P, Ozcelik H, Allingham-Hawkins D, et al (1999) Prevalence and penetrance of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241-1247